Salt of ABT-263 and solid-state forms thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8362013
APP PUB NO 20100305125A1
SERIAL NO

12770345

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

ABT-263 bis-HCl and crystalline polymorphs thereof are suitable active pharmaceutical ingredients for pharmaceutical compositions useful in treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ABBVIE INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Borchardt, Thomas Kenosha, US 9 376
Brackemeyer, Paul Mt. Prospect, US 1 28
Catron, Nathaniel Vernon Hills, US 16 340
Henry, Rodger Wildwood, US 17 354
Lou, Xiaochun Long Grove, US 25 208
Ravn, Matthew Round Lake Beach, US 2 46
Zhang, Geoff G Z Libertyville, US 42 276
Zhou, Deliang Vernon Hills, US 6 182

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 29, 2024
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00